Catalysts for $BMY
99 tracked
May 17, 2016
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Jan 23, 2016
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Nov 23, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Nov 23, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Oct 9, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Sep 30, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Apr 14, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Apr 14, 2015
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→
Dec 22, 2014
approval
OPDIVO (NIVOLUMAB) — FDA approval
nivolumab
→